Pharma firm La Renon acquires majority stake in Enaltec Labs
La Renon Healthcare, a pharmaceutical company backed by Sequoia Capital and A91 Partners, has acquired a 51 percent stake in Enaltec Labs. The transaction values Enaltec at Rs 180-200 crore post-money. “This is a structured deal where—based on Enaltec’s performance between October 2021 and September 2022, and after achieving about 15-18% Ebitda—the conversion of stake will be ascertained..,” La Renon’s Chief Financial Officer Amit Jain said. La Renon will end up with a higher stake than 51% if Enaltec fails to achieve those business targets, he said. “This is entirely…